Recursion Pharmaceuticals | DEFA14A: Others
Apr 23 17:21 ET
Recursion Pharmaceuticals | DEF 14A: Definitive information statements
Apr 23 17:21 ET
Recursion Pharmaceuticals | 8-K: Current report
Apr 16 08:05 ET
Recursion Pharmaceuticals | 8-K: Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Feb 27 22:39 ET
Recursion Pharmaceuticals | 8-K: Current report
Feb 7 17:02 ET
Recursion Pharmaceuticals | 8-K: Current report
Jan 31 16:43 ET
Recursion Pharmaceuticals | 8-K: Current report
Jan 8 00:00 ET
Recursion Pharmaceuticals | 8-K: Current report
Dec 20, 2023 08:01 ET
Recursion Pharmaceuticals | 8-K: Current report
Dec 15, 2023 08:41 ET
Recursion Pharmaceuticals | 8-K: Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
Nov 9, 2023 08:03 ET
Recursion Pharmaceuticals | 8-K: Current report
Oct 2, 2023 07:48 ET
Recursion Pharmaceuticals | 8-K: Current report
Sep 5, 2023 08:01 ET
Recursion Pharmaceuticals | 8-K/A: Current report (Amendment)
Aug 11, 2023 16:12 ET
Recursion Pharmaceuticals | 8-K: Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
Aug 8, 2023 08:03 ET
Recursion Pharmaceuticals | 8-K: Current report
Jul 12, 2023 08:32 ET
Recursion Pharmaceuticals | 8-K: Current report
Jun 20, 2023 17:09 ET
Recursion Pharmaceuticals | 8-K: Current report
Jun 13, 2023 08:14 ET
Recursion Pharmaceuticals | 8-K: Current report
Jun 9, 2023 07:28 ET
Recursion Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
May 30, 2023 17:14 ET
Recursion Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
May 30, 2023 17:12 ET
No Data
No Data